{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:37:57Z","timestamp":1767033477912,"version":"build-2065373602"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00210-025-04163-2","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T07:31:32Z","timestamp":1745307092000},"page":"13109-13120","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The intersection of GRK2 and PGE2 in rheumatoid arthritis: a comprehensive update on pathophysiology and treatment"],"prefix":"10.1007","volume":"398","author":[{"given":"Pankaj","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7501-3170","authenticated-orcid":false,"given":"Siddhi","family":"Bagwe Parab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"4163_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2174\/187153006779025711","volume":"6","author":"J Akaogi","year":"2006","unstructured":"Akaogi J, Nozaki T, Satoh M, Yamada H (2006) Role of PGE2 and EP receptors in the pathogenesis of rheumatoid arthritis and as a novel therapeutic strategy. Endocr Metab Immune Disord Drug Targets 6:383\u2013394. https:\/\/doi.org\/10.2174\/187153006779025711","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"4163_CR2","unstructured":"Mostafa Bahaa (2024) Paroxetine safety and efficacy in rheumatoid arthritis. Mostafa Bahaa. Accessed 24 Jul 2024"},{"key":"4163_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101773","volume":"36","author":"R Baker","year":"2022","unstructured":"Baker R, Narla R, Baker JF, Wysham KD (2022) Risk factors for osteoporosis and fractures in rheumatoid arthritis. Best Pract Res Clin Rheumatol 36:101773. https:\/\/doi.org\/10.1016\/j.berh.2022.101773","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4163_CR4","doi-asserted-by":"publisher","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","volume":"5","author":"RJ Black","year":"2023","unstructured":"Black RJ, Cross M, Haile LM et al (2023) Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol 5:e594\u2013e610. https:\/\/doi.org\/10.1016\/S2665-9913(23)00211-4","journal-title":"Lancet Rheumatol"},{"key":"4163_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/j.1527-3458.2001.tb00189.x","volume":"7","author":"M Bourin","year":"2001","unstructured":"Bourin M, Chue P, Guillon Y (2001) Paroxetine: a review. CNS Drug Rev 7:25\u201347. https:\/\/doi.org\/10.1111\/j.1527-3458.2001.tb00189.x","journal-title":"CNS Drug Rev"},{"key":"4163_CR6","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpba.2017.05.030","volume":"143","author":"A Cabrales-Rico","year":"2017","unstructured":"Cabrales-Rico A, Ramos Y, Besada V et al (2017) Development and validation of a bioanalytical method based on LC\u2013MS\/MS analysis for the quantitation of CIGB-814 peptide in plasma from Rheumatoid Arthritis patients. J Pharm Biomed Anal 143:130\u2013140. https:\/\/doi.org\/10.1016\/j.jpba.2017.05.030","journal-title":"J Pharm Biomed Anal"},{"key":"4163_CR7","doi-asserted-by":"publisher","first-page":"26239","DOI":"10.1038\/srep26239","volume":"6","author":"Y Chang","year":"2016","unstructured":"Chang Y, Jia X, Wei F et al (2016) CP-25, a novel compound, protects against autoimmune arthritis by modulating immune mediators of inflammation and bone damage. Sci Rep 6:26239. https:\/\/doi.org\/10.1038\/srep26239","journal-title":"Sci Rep"},{"key":"4163_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1055\/s-0031-1298327","volume":"78","author":"J-Y Chen","year":"2012","unstructured":"Chen J-Y, Wu H-X, Chen Y et al (2012) Paeoniflorin inhibits proliferation of fibroblast-like synoviocytes through suppressing G-protein-coupled receptor kinase 2. Planta Med 78:665\u2013671. https:\/\/doi.org\/10.1055\/s-0031-1298327","journal-title":"Planta Med"},{"key":"4163_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jep.2017.03.005","volume":"202","author":"L Chen","year":"2017","unstructured":"Chen L, Li J, Ke X et al (2017) The therapeutic effects of Periploca forrestii Schltr. stem extracts on collagen-induced arthritis by inhibiting the activation of Src\/NF-\u03baB signaling pathway in rats. J Ethnopharmacol 202:12\u201319. https:\/\/doi.org\/10.1016\/j.jep.2017.03.005","journal-title":"J Ethnopharmacol"},{"key":"4163_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3389\/fphar.2018.00563","volume":"9","author":"J Chen","year":"2018","unstructured":"Chen J, Wang Y, Wu H et al (2018) A modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice. Front Pharmacol 9:563. https:\/\/doi.org\/10.3389\/fphar.2018.00563","journal-title":"Front Pharmacol"},{"key":"4163_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106199","volume":"80","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang P, Liu Q et al (2020) Alleviating effect of paeoniflorin-6\u2032-O-benzene sulfonate in antigen-induced experimental Sj\u00f6gren\u2019s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK\/p38 signaling pathway. Int Immunopharmacol 80:106199. https:\/\/doi.org\/10.1016\/j.intimp.2020.106199","journal-title":"Int Immunopharmacol"},{"key":"4163_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/cells10020307","volume":"10","author":"J Cheng","year":"2021","unstructured":"Cheng J, Lucas PC, McAllister-Lucas LM (2021) Canonical and non-canonical roles of GRK2 in lymphocytes. Cells 10:307. https:\/\/doi.org\/10.3390\/cells10020307","journal-title":"Cells"},{"key":"4163_CR13","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1080\/08923973.2018.1434793","volume":"40","author":"N Choudhary","year":"2018","unstructured":"Choudhary N, Bhatt LK, Prabhavalkar KS (2018) Experimental animal models for rheumatoid arthritis. Immunopharmacol Immunotoxicol 40:193\u2013200. https:\/\/doi.org\/10.1080\/08923973.2018.1434793","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"4163_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","volume":"8","author":"Q Ding","year":"2023","unstructured":"Ding Q, Hu W, Wang R et al (2023) Signaling pathways in rheumatoid arthritis: implications for targeted therapy. Signal Transduct Target Ther 8:68","journal-title":"Signal Transduct Target Ther"},{"key":"4163_CR15","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1523\/JNEUROSCI.5752-09.2010","volume":"30","author":"N Eijkelkamp","year":"2010","unstructured":"Eijkelkamp N, Heijnen CJ, Willemen HLDM et al (2010) GRK2: a novel cell-specific regulator of severity and duration of inflammatory pain. J Neurosci 30:2138\u20132149. https:\/\/doi.org\/10.1523\/JNEUROSCI.5752-09.2010","journal-title":"J Neurosci"},{"key":"4163_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00827-y","author":"A Finckh","year":"2022","unstructured":"Finckh A, Gilbert B, Hodkinson B et al (2022) Global epidemiology of rheumatoid arthritis. Nat Rev Rheumatol. https:\/\/doi.org\/10.1038\/s41584-022-00827-y","journal-title":"Nat Rev Rheumatol"},{"key":"4163_CR17","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T et al (2022) The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther 7:376. https:\/\/doi.org\/10.1038\/s41392-022-01191-9","journal-title":"Signal Transduct Target Ther"},{"key":"4163_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12964-023-01358-z","volume":"21","author":"M Ge","year":"2023","unstructured":"Ge M, Wu L, He F et al (2023) CP-25 inhibits the hyperactivation of rheumatic synoviocytes by suppressing the switch in G\u03b1s-G\u03b1i coupling to the \u03b22-adrenergic receptor. Cell Commun Signal 21:346. https:\/\/doi.org\/10.1186\/s12964-023-01358-z","journal-title":"Cell Commun Signal"},{"key":"4163_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2023.12.007","author":"P Guo","year":"2023","unstructured":"Guo P, Jiang J, Chu R et al (2023) GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis. Acta Pharm Sin B. https:\/\/doi.org\/10.1016\/j.apsb.2023.12.007","journal-title":"Acta Pharm Sin B"},{"key":"4163_CR20","doi-asserted-by":"publisher","first-page":"987","DOI":"10.3892\/ijmm.2016.2720","volume":"38","author":"C-C Han","year":"2016","unstructured":"Han C-C, Ma Y, Li Y et al (2016) Regulatory effects of GRK2 on GPCRs and non-GPCRs and possible use as a drug target (Review). Int J Mol Med 38:987\u2013994. https:\/\/doi.org\/10.3892\/ijmm.2016.2720","journal-title":"Int J Mol Med"},{"key":"4163_CR21","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1159\/000495329","volume":"51","author":"C Han","year":"2018","unstructured":"Han C, Li Y, Wang Y et al (2018) Development of inflammatory immune response-related drugs based on G protein-coupled receptor kinase 2. Cell Physiol Biochem 51:729\u2013745. https:\/\/doi.org\/10.1159\/000495329","journal-title":"Cell Physiol Biochem"},{"key":"4163_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1042\/CS20191032","volume":"134","author":"C-C Han","year":"2020","unstructured":"Han C-C, Liu Q, Zhang Y et al (2020) CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4\/AC\/cAMP\/PKA-mediated GRK2 translocation. Clin Sci 134:331\u2013347. https:\/\/doi.org\/10.1042\/CS20191032","journal-title":"Clin Sci"},{"key":"4163_CR23","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.apsb.2021.01.015","volume":"11","author":"C Han","year":"2021","unstructured":"Han C, Li Y, Zhang Y et al (2021) Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats. Acta Pharm Sin B 11:1835\u20131852. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.015","journal-title":"Acta Pharm Sin B"},{"key":"4163_CR24","doi-asserted-by":"publisher","first-page":"4566851","DOI":"10.1155\/2022\/4566851","volume":"2022","author":"Z Hong","year":"2022","unstructured":"Hong Z, Zhang X, Zhang T et al (2022) The ROS\/GRK2\/HIF-1 \u03b1 \/NLRP3 pathway mediates pyroptosis of fibroblast-like synoviocytes and the regulation of monomer derivatives of paeoniflorin. Oxid Med Cell Longev 2022:4566851. https:\/\/doi.org\/10.1155\/2022\/4566851","journal-title":"Oxid Med Cell Longev"},{"key":"4163_CR25","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/biomedicines10081950","volume":"10","author":"N Honke","year":"2022","unstructured":"Honke N, Wiest CJ, Pongratz G (2022) \u03b22-adrenergic receptor expression and intracellular signaling in B cells are highly dynamic during collagen-induced arthritis. Biomedicines 10:1950. https:\/\/doi.org\/10.3390\/biomedicines10081950","journal-title":"Biomedicines"},{"key":"4163_CR26","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s10787-019-00575-8","volume":"27","author":"X Jia","year":"2019","unstructured":"Jia X, Chang Y, Sun X et al (2019) Regulatory effects of paeoniflorin-6\u2032-O-benzene sulfonate (CP-25) on dendritic cells maturation and activation via PGE2-EP4 signaling in adjuvant-induced arthritic rats. Inflammopharmacology 27:997\u20131010. https:\/\/doi.org\/10.1007\/s10787-019-00575-8","journal-title":"Inflammopharmacology"},{"key":"4163_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22464","volume":"34","author":"M Kabiri","year":"2020","unstructured":"Kabiri M, Hemmatpour A, Zare F et al (2020) Paroxetine modulates immune responses by activating a JAK2\/STAT3 signaling pathway. J Biochem Mol Toxicol 34:e22464. https:\/\/doi.org\/10.1002\/jbt.22464","journal-title":"J Biochem Mol Toxicol"},{"key":"4163_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s10787-024-01445-8","author":"C Kaur","year":"2024","unstructured":"Kaur C, Mishra Y, Kumar R et al (2024) Pathophysiology, diagnosis, and herbal medicine-based therapeutic implication of rheumatoid arthritis: an overview. Inflammopharmacology. https:\/\/doi.org\/10.1007\/s10787-024-01445-8","journal-title":"Inflammopharmacology"},{"key":"4163_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1600-0447.1989.tb07176.x","volume":"80","author":"CM Kaye","year":"1989","unstructured":"Kaye CM, Haddock RE, Langley PF et al (1989) A review of the metabolism and pharmacokinetics of paroxetine in man. Acta Psychiatr Scand 80:60\u201375. https:\/\/doi.org\/10.1111\/j.1600-0447.1989.tb07176.x","journal-title":"Acta Psychiatr Scand"},{"key":"4163_CR30","doi-asserted-by":"publisher","first-page":"698424","DOI":"10.3389\/fimmu.2021.698424","volume":"12","author":"J Kuai","year":"2021","unstructured":"Kuai J, Han C, Wei W (2021) Potential regulatory roles of GRK2 in endothelial cell activity and pathological angiogenesis. Front Immunol 12:698424","journal-title":"Front Immunol"},{"key":"4163_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.5114\/reum.2016.60212","volume":"54","author":"EH Kuca-Warnawin","year":"2016","unstructured":"Kuca-Warnawin EH, Kurowska WJ, Radzikowska A et al (2016) Different expression of chemokines in rheumatoid arthritis and osteoarthritis bone marrow. Rheumatology 54:51\u201353. https:\/\/doi.org\/10.5114\/reum.2016.60212","journal-title":"Rheumatology"},{"key":"4163_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/biomedicines11020445","volume":"11","author":"A Kulesza","year":"2023","unstructured":"Kulesza A, Paczek L, Burdzinska A (2023) The role of COX-2 and PGE2 in the regulation of immunomodulation and other functions of mesenchymal stromal cells. Biomedicines 11:445. https:\/\/doi.org\/10.3390\/biomedicines11020445","journal-title":"Biomedicines"},{"key":"4163_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4161\/cam.21585","volume":"6","author":"V Lafarga","year":"2012","unstructured":"Lafarga V, Mayor JF, Penela P (2012) The interplay between G protein-coupled receptor kinase 2 (GRK2) and histone deacetylase 6 (HDAC6) at the crossroads of epithelial cell motility. Cell Adh Migr 6:495\u2013501. https:\/\/doi.org\/10.4161\/cam.21585","journal-title":"Cell Adh Migr"},{"key":"4163_CR34","doi-asserted-by":"publisher","first-page":"e567","DOI":"10.1016\/S2665-9913(23)00240-0","volume":"5","author":"CS Lau","year":"2023","unstructured":"Lau CS (2023) Burden of rheumatoid arthritis and forecasted prevalence to 2050. Lancet Rheumatol 5:e567\u2013e568. https:\/\/doi.org\/10.1016\/S2665-9913(23)00240-0","journal-title":"Lancet Rheumatol"},{"key":"4163_CR35","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2147\/JIR.S444758","volume":"17","author":"M Li","year":"2024","unstructured":"Li M, Zhang F-J, Bai R-J (2024) The Hippo-YAP signaling pathway in osteoarthritis and rheumatoid arthritis. J Inflamm Res 17:1105\u20131120. https:\/\/doi.org\/10.2147\/JIR.S444758","journal-title":"J Inflamm Res"},{"key":"4163_CR36","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.pop.2018.02.010","volume":"45","author":"EA Littlejohn","year":"2018","unstructured":"Littlejohn EA, Monrad SU (2018) Early diagnosis and treatment of rheumatoid arthritis. Prim Care Clin Off Pract 45:237\u2013255. https:\/\/doi.org\/10.1016\/j.pop.2018.02.010","journal-title":"Prim Care Clin Off Pract"},{"key":"4163_CR37","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/CIRCRESAHA.124.323067","volume":"135","author":"S Liu","year":"2024","unstructured":"Liu S, Anderson PJ, Rajagopal S et al (2024) G protein-coupled receptors: a century of research and discovery. Circ Res 135:174\u2013197. https:\/\/doi.org\/10.1161\/CIRCRESAHA.124.323067","journal-title":"Circ Res"},{"key":"4163_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003165","author":"T Liu","year":"2024","unstructured":"Liu T, Jin C, Sun J et al (2024) Paroxetine alleviates dendritic cell and T lymphocyte activation via GRK2-mediated PI3K\u2013AKT signaling in rheumatoid arthritis. Chin Med J (Engl). https:\/\/doi.org\/10.1097\/CM9.0000000000003165","journal-title":"Chin Med J (Engl)"},{"key":"4163_CR39","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.4049\/jimmunol.166.3.1635","volume":"166","author":"MS Lombardi","year":"2001","unstructured":"Lombardi MS, Kavelaars A, Cobelens PM et al (2001) Adjuvant arthritis induces down-regulation of G protein-coupled receptor kinases in the immune system. J Immunol 166:1635\u20131640. https:\/\/doi.org\/10.4049\/jimmunol.166.3.1635","journal-title":"J Immunol"},{"key":"4163_CR40","doi-asserted-by":"publisher","first-page":"15642","DOI":"10.1073\/pnas.1519644112","volume":"112","author":"B Luan","year":"2015","unstructured":"Luan B, Yoon Y-S, Le Lay J et al (2015) CREB pathway links PGE2 signaling with macrophage polarization. Proc Nat Acad Sci 112:15642\u201315647. https:\/\/doi.org\/10.1073\/pnas.1519644112","journal-title":"Proc Nat Acad Sci"},{"key":"4163_CR41","doi-asserted-by":"publisher","first-page":"942417","DOI":"10.3389\/fimmu.2022.942417","volume":"13","author":"DE Mahmoud","year":"2022","unstructured":"Mahmoud DE, Kaabachi W, Sassi N et al (2022) The synovial fluid fibroblast-like synoviocyte: a long-neglected piece in the puzzle of rheumatoid arthritis pathogenesis. Front Immunol 13:942417","journal-title":"Front Immunol"},{"key":"4163_CR42","unstructured":"Mahmoud Samy Abdallah (2024) The GRK2 inhibitor paroxetine as a novel adjunct to conventional therapy in rheumatoid arthritis patients. The GRK2 inhibitor paroxetine as a novel adjunct to conventional therapy in rheumatoid arthritis patients. Accessed 24 Jul 2024"},{"key":"4163_CR43","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fimmu.2015.00384","volume":"6","author":"M Mellado","year":"2015","unstructured":"Mellado M (2015) T cell migration in rheumatoid arthritis. Front Immunol 6:384. https:\/\/doi.org\/10.3389\/fimmu.2015.00384","journal-title":"Front Immunol"},{"key":"4163_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Meng Z, Moroishi T, Guan K-L (2016) Mechanisms of Hippo pathway regulation. Genes Dev 30:1\u201317. https:\/\/doi.org\/10.1101\/gad.274027.115","journal-title":"Genes Dev"},{"key":"4163_CR45","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.cellsig.2005.01.002","volume":"17","author":"T M\u00e9tay\u00e9","year":"2005","unstructured":"M\u00e9tay\u00e9 T, Gibelin H, Perdrisot R, Kraimps J-L (2005) Pathophysiological roles of G-protein-coupled receptor kinases. Cell Signal 17:917\u2013928. https:\/\/doi.org\/10.1016\/j.cellsig.2005.01.002","journal-title":"Cell Signal"},{"key":"4163_CR46","doi-asserted-by":"publisher","first-page":"112","DOI":"10.3389\/fphar.2019.00112","volume":"10","author":"C Murga","year":"2019","unstructured":"Murga C, Arcones AC, Cruces-Sande M et al (2019) G protein-coupled receptor kinase 2 (GRK2) as a potential therapeutic target in cardiovascular and metabolic diseases. Front Pharmacol 10:112","journal-title":"Front Pharmacol"},{"key":"4163_CR47","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1080\/14397595.2016.1213481","volume":"27","author":"T Nanki","year":"2017","unstructured":"Nanki T, Imai T, Kawai S (2017) Fractalkine\/CX3CL1 in rheumatoid arthritis. Mod Rheumatol 27:392\u2013397. https:\/\/doi.org\/10.1080\/14397595.2016.1213481","journal-title":"Mod Rheumatol"},{"key":"4163_CR48","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/gene.2015.26","volume":"16","author":"N Packiriswamy","year":"2015","unstructured":"Packiriswamy N, Parameswaran N (2015) G-protein-coupled receptor kinases in inflammation and disease. Genes Immun 16:367\u2013377. https:\/\/doi.org\/10.1038\/gene.2015.26","journal-title":"Genes Immun"},{"key":"4163_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/13813450802181039","volume":"114","author":"P Penela","year":"2008","unstructured":"Penela P, Murga C, Ribas C et al (2008) G protein-coupled receptor kinase 2 (GRK2) in migration and inflammation. Arch Physiol Biochem 114:195\u2013200. https:\/\/doi.org\/10.1080\/13813450802181039","journal-title":"Arch Physiol Biochem"},{"key":"4163_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152249","volume":"62","author":"JA Sparks","year":"2023","unstructured":"Sparks JA, Harrold LR, Simon TA et al (2023) Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: a systematic review. Semin Arthritis Rheum 62:152249. https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152249","journal-title":"Semin Arthritis Rheum"},{"key":"4163_CR51","doi-asserted-by":"crossref","unstructured":"Steury MD, McCabe LR, Parameswaran N (2017) G protein-coupled receptor kinases in the inflammatory response and signaling. pp 227\u2013277","DOI":"10.1016\/bs.ai.2017.05.003"},{"key":"4163_CR52","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/s41401-021-00654-z","volume":"43","author":"Y Tai","year":"2022","unstructured":"Tai Y, Huang B, Guo P et al (2022) TNF-\u03b1 impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes. Acta Pharmacol Sin 43:401\u2013416. https:\/\/doi.org\/10.1038\/s41401-021-00654-z","journal-title":"Acta Pharmacol Sin"},{"key":"4163_CR53","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1517\/14656566.9.5.787","volume":"9","author":"SW Tang","year":"2008","unstructured":"Tang SW, Helmeste D (2008) Paroxetine. Expert Opin Pharmacother 9:787\u2013794. https:\/\/doi.org\/10.1517\/14656566.9.5.787","journal-title":"Expert Opin Pharmacother"},{"key":"4163_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109432","volume":"119","author":"H Tang","year":"2019","unstructured":"Tang H, Wu Y, Xiao F et al (2019) Regulation of CP-25 on P-glycoprotein in synoviocytes of rats with adjuvant arthritis. Biomed Pharmacother 119:109432. https:\/\/doi.org\/10.1016\/j.biopha.2019.109432","journal-title":"Biomed Pharmacother"},{"key":"4163_CR55","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2147\/NDT.S109880","volume":"12","author":"X Tian","year":"2016","unstructured":"Tian X, Wang Q, Guo R et al (2016) Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction. Neuropsychiatr Dis Treat 12:2333\u20132341. https:\/\/doi.org\/10.2147\/NDT.S109880","journal-title":"Neuropsychiatr Dis Treat"},{"key":"4163_CR56","doi-asserted-by":"publisher","first-page":"45364","DOI":"10.1038\/srep45364","volume":"7","author":"Q Wang","year":"2017","unstructured":"Wang Q, Wang L, Wu L et al (2017) Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis. Sci Rep 7:45364. https:\/\/doi.org\/10.1038\/srep45364","journal-title":"Sci Rep"},{"key":"4163_CR57","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1007\/s10753-018-0757-z","volume":"41","author":"Y Wang","year":"2018","unstructured":"Wang Y, Han C, Cui D et al (2018) Immunomodulatory effects of CP-25 on splenic T cells of rats with adjuvant arthritis. Inflammation 41:1049\u20131063. https:\/\/doi.org\/10.1007\/s10753-018-0757-z","journal-title":"Inflammation"},{"key":"4163_CR58","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.bbrc.2020.03.164","volume":"526","author":"D-D Wang","year":"2020","unstructured":"Wang D-D, Jiang M-Y, Wang W et al (2020) Paeoniflorin-6\u2032-O-benzene sulfonate down-regulates CXCR4-G\u03b2\u03b3-PI3K\/AKT mediated migration in fibroblast-like synoviocytes of rheumatoid arthritis by inhibiting GRK2 translocation. Biochem Biophys Res Commun 526:805\u2013812. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.164","journal-title":"Biochem Biophys Res Commun"},{"key":"4163_CR59","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/14397595.2019.1651446","volume":"30","author":"J Wei","year":"2020","unstructured":"Wei J, Ouyang X, Tang Y et al (2020) ER-stressed MSC displayed more effective immunomodulation in RA CD4 + CXCR5 + ICOS + follicular helper-like T cells through higher PGE2 binding with EP2\/EP4. Mod Rheumatol 30:509\u2013516. https:\/\/doi.org\/10.1080\/14397595.2019.1651446","journal-title":"Mod Rheumatol"},{"key":"4163_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41590-020-00816-x","volume":"22","author":"CM Weyand","year":"2021","unstructured":"Weyand CM, Goronzy JJ (2021) The immunology of rheumatoid arthritis. Nat Immunol 22:10\u201318. https:\/\/doi.org\/10.1038\/s41590-020-00816-x","journal-title":"Nat Immunol"},{"key":"4163_CR61","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fphar.2018.00004","volume":"9","author":"Y Wu","year":"2018","unstructured":"Wu Y, Chen H, Chen W et al (2018) CP-25 attenuates the activation of CD4+ T cells stimulated with immunoglobulin D in human. Front Pharmacol 9:4. https:\/\/doi.org\/10.3389\/fphar.2018.00004","journal-title":"Front Pharmacol"},{"key":"4163_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107392","volume":"93","author":"Z Wu","year":"2021","unstructured":"Wu Z, Ma D, Yang H et al (2021) Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes. Int Immunopharmacol 93:107392. https:\/\/doi.org\/10.1016\/j.intimp.2021.107392","journal-title":"Int Immunopharmacol"},{"key":"4163_CR63","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41401-020-00510-6","volume":"41","author":"X-Z Yang","year":"2020","unstructured":"Yang X-Z, Wei W (2020) CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases. Acta Pharmacol Sin 41:1387\u20131394","journal-title":"Acta Pharmacol Sin"},{"key":"4163_CR64","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/cells8121596","volume":"8","author":"X Yang","year":"2019","unstructured":"Yang X, Li S, Zhao Y et al (2019) GRK2 mediated abnormal transduction of PGE2-EP4-cAMP-CREB signaling induces the imbalance of macrophages polarization in collagen-induced arthritis mice. Cells 8:1596. https:\/\/doi.org\/10.3390\/cells8121596","journal-title":"Cells"},{"key":"4163_CR65","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.biopha.2018.12.040","volume":"110","author":"X Yang","year":"2019","unstructured":"Yang X, Zhao Y, Jia X et al (2019) CP-25 combined with MTX\/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomed Pharmacother 110:834\u2013843. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.040","journal-title":"Biomed Pharmacother"},{"key":"4163_CR66","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.apsb.2023.09.013","volume":"14","author":"X Yang","year":"2024","unstructured":"Yang X, Zhao Y, Wei Q et al (2024) GRK2 inhibits Flt-1+ macrophage infiltration and its proangiogenic properties in rheumatoid arthritis. Acta Pharm Sin B 14:241\u2013255. https:\/\/doi.org\/10.1016\/j.apsb.2023.09.013","journal-title":"Acta Pharm Sin B"},{"key":"4163_CR67","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.1096\/fasebj.2022.36.S1.L7919","volume":"36","author":"NK Yoshioka","year":"2022","unstructured":"Yoshioka NK, Karuppagounder V, Pinamont WJ et al (2022) GRK2, a novel regulator of skeletal development. FASEB J 36:7919. https:\/\/doi.org\/10.1096\/fasebj.2022.36.S1.L7919","journal-title":"FASEB J"},{"key":"4163_CR68","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","volume":"20","author":"F Zhang","year":"2019","unstructured":"Zhang F, Wei K, Slowikowski K et al (2019) Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol 20:928\u2013942. https:\/\/doi.org\/10.1038\/s41590-019-0378-1","journal-title":"Nat Immunol"},{"key":"4163_CR69","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10765","author":"M Zhang","year":"2019","unstructured":"Zhang M, Gao M, Chen J et al (2019) CP-25 exerts anti-angiogenic effects on a rat model of adjuvant-induced arthritis by promoting GRK2-induced downregulation of CXCR4-ERK1\/2 signaling in endothelial cells. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2019.10765","journal-title":"Mol Med Rep"},{"key":"4163_CR70","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3892\/etm.2022.11450","volume":"24","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Yang X, Han C et al (2022) Paeoniflorin-6\u2032O-benzene sulfonate suppresses fibroblast-like synoviocytes proliferation and migration in rheumatoid arthritis through regulating GRK2-G\u03b2\u03b3 interaction. Exp Ther Med 24:523. https:\/\/doi.org\/10.3892\/etm.2022.11450","journal-title":"Exp Ther Med"},{"key":"4163_CR71","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/ph16050664","volume":"16","author":"J Zhang","year":"2023","unstructured":"Zhang J, Zhang X, Lu M et al (2023) GRK2 mediates macrophage polarization by regulating EP4-cAMP-pCREB signaling in ulcerative colitis and the therapeutic effect of paroxetine on mice with DSS-induced colitis. Pharmaceuticals 16:664. https:\/\/doi.org\/10.3390\/ph16050664","journal-title":"Pharmaceuticals"},{"key":"4163_CR72","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s10787-018-0463-3","volume":"27","author":"M Zhao","year":"2019","unstructured":"Zhao M, Zhou P, Yu J et al (2019) The tissue distribution and excretion study of paeoniflorin-6\u2032-O-benzene sulfonate (CP-25) in rats. Inflammopharmacology 27:969\u2013974. https:\/\/doi.org\/10.1007\/s10787-018-0463-3","journal-title":"Inflammopharmacology"},{"key":"4163_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.907733","volume":"13","author":"J Zhao","year":"2022","unstructured":"Zhao J, Wei K, Jiang P et al (2022) G-protein-coupled receptors in rheumatoid arthritis: recent insights into mechanisms and functional roles. Front Immunol 13:907733. https:\/\/doi.org\/10.3389\/fimmu.2022.907733","journal-title":"Front Immunol"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04163-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04163-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:13:11Z","timestamp":1759983191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04163-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":73,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4163"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04163-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}